Earnings Feed
Start Free
$CRNX·8-K

Crinetics Pharmaceuticals, Inc. · Feb 26, 4:15 PM ET

Crinetics Pharmaceuticals, Inc. 8-K

Research Summary

AI-generated summary

Updated

Crinetics Pharmaceuticals Reports Results for Period Ended Dec 31, 2025

What Happened
Crinetics Pharmaceuticals, Inc. announced on February 26, 2026 that it issued a press release reporting the company's financial results for the period ended December 31, 2025. The press release is attached to the Form 8‑K as Exhibit 99.1. The filing is made under Item 2.02 (Results of Operations and Financial Condition).

Key Details

  • Filing date: February 26, 2026.
  • Reporting period: financial results for the period ended December 31, 2025.
  • Exhibit: Press release attached as Exhibit 99.1 to the Form 8‑K.
  • Signature: Form 8‑K signed by R. Scott Struthers, Ph.D., President and CEO.

Why It Matters
This 8‑K signals that Crinetics has publicly released its recent earnings/financial results; investors should read the attached press release for revenue, earnings, cash position, and any business or pipeline updates. The filing notes the press release is furnished (not “filed”) under SEC rules, which affects legal incorporation and liability under Section 18 of the Exchange Act.